ReCon Chat with Bob...
Health Care: Drugs
Cleveland BioLabs Inc. (CBLI: NASDAQ)
$1.64 0.04 | 2.50%
05/23/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 25.65M | 22.87M | 10.92M | 963.10K |
| Receivables | 41.90K | 1.74M | 5.38M | 3.39M |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 1.08M | 876.89K | 991.06K | 381.03K |
| Total Current Assets | 29.41M | 31.01M | 17.75M | 4.74M |
| Property, Plant & Equipment, Gross | 2.76M | 2.60M | 2.33M | 1.86M |
| Accumulated Depreciation & Depletion | 1.78M | 1.51M | 1.38M | 995.41K |
| Property, Plant & Equipment, Net | 986.55K | 1.08M | 941.12K | 864.91K |
| Intangibles | 0.00 | 0.00 | 1.16M | 929.98K |
| Other Non-Current Assets | 1.62M | 32.49K | 32.11K | 23.48K |
| Total Non-Current Assets | 2.60M | 1.12M | 2.14M | 1.82M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 32.01M | 32.13M | 19.89M | 6.55M |
| Accounts Payable | 1.52M | 909.14K | 1.26M | 1.21M |
| Short Term Debt | 71.68K | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 11.43M | 9.88M | 30.42M | 13.35M |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 0.00 | 0.00 | 1.97M | 0.00 |
| Minority Interest | -4.18M | -1.22M | -305.81K | 0.00 |
| Total Non-Current Liabilities | 14.25M | 13.18M | 5.17M | 0.00 |
| Total Liabilities | 25.68M | 23.07M | 35.58M | 13.35M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 2.00 |
| Common Stock Equity | 6.33M | 9.06M | -15.70M | -6.80M |
| Common Par | 223.65K | 178.06K | 144.80K | 101.02K |
| Additional Paid In Capital | 123.86M | 108.87M | 80.24M | 62.79M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -118.30M | -100.07M | -96.05M | -69.69M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 546.47K | 84.61K | -30.54K | 0.00 |
| Total Capitalization | 6.33M | 9.06M | -15.70M | -6.80M |
| Total Equity | 6.33M | 9.06M | -15.70M | -6.80M |
| Total Liabilities & Stock Equity | 32.01M | 32.13M | 19.89M | 6.55M |
| Total Common Shares Outstanding | 44.73M | 35.61M | 28.96M | 20.20M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 467.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 37.39M | 32.56M | 26.18M | 16.41M |
| Diluted Weighted Shares Outstanding | 37.39M | 32.56M | 26.18M | 16.41M |
| Number of Employees | 85 | 58 | 52 | 36 |
| Number of Part-Time Employees | 0 | 2 | 3 | 2 |
Portfolios with CBLI
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Contributor5 Health Care Stocks With U...
- Contributor10 Surging Stocks Most at R...
- UserNEW HOME savings
- UserDan128
- UserJustchattin Portfolio 1
- UserSPQR
Latest CBLI Headlines from TheStreet
- Cleveland BioLabs Strengthens Clinical Development Team 04.08.13 | 10:04 am
- Cleveland BioLabs And Incuron Announce Notice Of Allowance From FDA To Commence Clinical Testing With CBL0137 04.02.13 | 07:04 am
- 5 Stocks Under $10 Triggering Breakouts 03.21.13 | 01:03 pm
- Cleveland BioLabs Reports Fourth Quarter And Fiscal 2012 Financial Results And Development Progress 03.14.13 | 07:03 am
- Cleveland BioLabs To Report Fiscal 2012 Financial Results And Provide Operational Update On March 14 03.08.13 | 09:03 am
- Cleveland BioLabs To Present At 15th Annual BIO CEO And Investor Conference 02.05.13 | 07:02 am
- Cleveland BioLabs To Present At BARDA And NIAID Sponsored Symposium On Development Of Radiation Medical Countermeasures 01.24.13 | 07:01 am
- Cleveland BioLabs Prices $15 Million Public Offering Of Common Stock And Warrants 10.19.12 | 09:10 am
- Cleveland BioLabs Announces Proposed Public Offering Of Common Stock And Warrants 10.18.12 | 04:10 pm
- Cleveland BioLabs Submits Proposal To BARDA For Development Funding For Entolimod(TM) (CBLB502) 10.18.12 | 07:10 am
Press Releases for CBLI
- Cleveland BioLabs To Present At Second Annual Marcum LLP Microcap Conference - PR Newswire 05.22.13 | 08:05 am
- Mintz Levin Represents Cleveland Biolabs, Inc. In $8.4 Million Direct Offering - Business Wire 01.04.11 | 09:01 am
Partner Headlines for CBLI
- Acute Radiation Syndrome, Are We Prepared And Who Is Best Preparing Us? - Seeking Alpha 02.27.13 | 09:02 am
- Five Micro Cap Stocks With Recent Insider Buys - Benzinga 07.06.12 | 05:07 pm
- Morning Market Losers - Benzinga 06.05.12 | 09:06 am
- Morning Market Movers - Benzinga 06.04.12 | 09:06 am
- Ultimate Market Recap: Medtox Makes Good, BofA Holds Out on Shareholders - Wall St. Cheat Sheet 06.04.12 | 07:06 am
- 3 Stocks Illuminating Green on a Red Trading Day - Wall St. Cheat Sheet 06.04.12 | 02:06 am
- Will the Next Apple or Google Be Found Among These Micro Caps? - Seeking Alpha 08.18.11 | 09:08 am
- Rodman & Renshaw Lower Cleveland BioLabs PT to $8 - Benzinga 06.27.11 | 04:06 pm
- Zacks #5 Rank Additions for Monday - Tale of the Tape - Zacks 06.20.11 | 09:06 am
- Future Biotech Superstars - Seeking Alpha 03.30.11 | 09:03 am
